But we have had things on the buy list for the last two years that are still too expensive.

The stock is not on your buy list, but you recently gave it an outperform rating.

If you could get stock in a prospect, he'd be near the top of the buy list.

Nomura, forecasting year's profits of £273m against last time's £229.1m, has put the shares on its buy list.

He added familiar names to his buy list.

He recently added SmithKline to his buy list, along with most other big drug makers.

But, Staples is the only one on his buy list.

"The stock remains on our long-term buy list," he said Friday.

Still, in the last few months several analysts have added a few biotechnology stocks to their buy lists.

"I took it off the buy list on June 4 at $29," he said.